Zenfo Med Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.13 M
- Revenue Growth 22449.45%
- Profit Growth 44292.47%
- Ebitda 73493.04%
- Net Worth 37055.16%
- Total Assets 18090.32%
About Zenfo Med Remedies
Zenfo Med Remedies Private Limited (ZMRPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 March 2021 (Three years and 11 months 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.13 M.
Ashok Sama and Shivakoti Ravi serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290TG2021PTC149745
- Company No.
149745
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2021
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Zenfo Med Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Sama  | Director | 18-Mar-2021 | Current |
| Shivakoti Ravi | Director | 18-Mar-2021 | Current |
Financial Performance of Zenfo Med Remedies.
Zenfo Med Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22449.45% increase. The company also saw a substantial improvement in profitability, with a 44292.47% increase in profit. The company's net worth Soared by an impressive increase of 37055.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenfo Med Remedies?
Unlock access to Zenfo Med Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Velchi Pharma Private LimitedShivakoti Ravi is a mutual person
Charges (Loans)
₹3.13 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Axis Bank Limited | ₹3.13 M | Open |
How Many Employees Work at Zenfo Med Remedies?
Zenfo Med Remedies has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenfo Med Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenfo Med Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
